Treatment of adult hyper-IgD syndrome with canakinumab

J Allergy Clin Immunol Pract. 2015 Sep-Oct;3(5):817-8. doi: 10.1016/j.jaip.2015.05.020. Epub 2015 Jun 25.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antibodies, Monoclonal / administration & dosage*
  • Antibodies, Monoclonal / adverse effects
  • Antibodies, Monoclonal, Humanized
  • DNA Mutational Analysis
  • Delayed Diagnosis
  • Female
  • Humans
  • Immunotherapy / methods*
  • Interleukin-1beta / immunology
  • Mevalonate Kinase Deficiency / diagnosis*
  • Mevalonate Kinase Deficiency / immunology
  • Mevalonate Kinase Deficiency / therapy
  • Mutation / genetics
  • Phosphotransferases (Alcohol Group Acceptor) / genetics*

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Interleukin-1beta
  • canakinumab
  • Phosphotransferases (Alcohol Group Acceptor)
  • mevalonate kinase